06 August 2020
All volunteers inoculated with the vaccine against the coronavirus developed by the Vektor State Research Center of Virology and Biotechnology are in good health, no side effects of the vaccination are observed, the press service of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing told TASS on August 4.
“All vaccinated volunteers are in good health. No complications after the inoculation with the EpiVacCorona vaccine against the coronavirus have been recorded,” the statement said.
To date, three volunteers out of five have already been inoculated. The fourth one will be vaccinated on August 5. The sanitary watchdog noted that the volunteers remain under constant medical observation while no situations requiring medical aid arose.
“Double vaccination after 21 days is planned. The vaccine should facilitate the development of the immunity against the novel coronavirus infection after double administration with a 21-day interval. The data collection on the antibody levels will begin already after the first inoculation,” the press service explained.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
New breast cancer guidelines call for first mammogram at age 40 but stop short of annual screening
08 May 2024
WHO proposes recommendations for preventing nitrosamine contamination
07 May 2024
Batyr Berdyklychev is now head of the WHO office in Russia
07 May 2024
Russia expects more medical tourism due to the world’s first drug for ankylosing spondylitis
07 May 2024